Pediatric Cancer
Pediatric cancer refers to a group of cancers affecting children and teenagers, aged from infancy to 19 years. Though rare, these cancers profoundly impact young patients and their families. Recent advancements in treatment have significantly improved survival rates, with over 80% of affected children living five years or more post-diagnosis. However, survivors often face long-term health challenges, emphasizing the need for continued care and monitoring.
Causes of Pediatric Cancer
Unclear Causes: Childhood cancers don’t have well-defined causes, but genetic mutations during early development play a major role.
Difference from Adult Cancers: Unlike adult cancers tied to environmental exposures or aging, pediatric cancers often result from inherited conditions or DNA replication errors.
Genetic Disorders: Conditions such as Li-Fraumeni Syndrome and Fanconi Anemia raise the risk, making early screening important for high-risk children.
Pediatric cancers are classified into three major categories:
Based on the type of cells and tissues affected, pediatric cancers are grouped into three main categories.
Leukemias: Affecting blood and bone marrow, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
Brain Tumours: Both benign and malignant types, being the most common childhood cancer.
Solid Tumours: Such as neuroblastoma, Wilms tumour, retinoblastoma, and bone cancers (e.g., osteosarcoma, Ewing sarcoma).
Diagnosis of Pediatric Cancer
Childhood cancers are often discovered through persistent symptoms or routine examinations. Diagnostic methods include:
Blood Tests Identifying abnormalities indicative of conditions like leukemia.
Imaging Tests Including CT scans, MRIs, and ultrasounds to detect tumours.
Biopsy Sampling tissue for pathological examination.
Bone Marrow and Lumbar Puncture Identifying cancer in blood-forming tissues and cerebrospinal fluid.
Timely and accurate diagnosis is critical to determine the type and stage of cancer, enabling an effective treatment plan.
Treatment Options for Pediatric Cancer
Childhood cancer treatment varies based on the type and stage of cancer, as well as the child’s age and overall health. Common treatments include:
Radiation Therapy
Radiation therapy uses high-energy rays or particles to kill cancer cells by damaging their DNA, which prevents them from growing and dividing. For children, radiation is often employed to treat brain tumours, bone cancers, and other solid tumours. Techniques like external beam radiation and proton therapy allow for precise targeting of the cancer, minimising harm to surrounding healthy tissues. Side effects can include fatigue, skin irritation, and, in some cases, long-term impacts on growth and cognitive development. Paediatric oncologists carefully tailor radiation plans to balance efficacy with the preservation of the child’s overall health and quality of life.
Chemotherapy
Chemotherapy is the cornerstone of childhood cancer treatment, involving the use of potent drugs to target and destroy rapidly dividing cancer cells. These drugs can be administered through various methods, including intravenous infusion, oral medication, or directly into cerebrospinal fluid for cancers affecting the brain and spinal cord. While effective in combating cancers like leukaemia, lymphoma, and solid tumours, chemotherapy often impacts healthy cells, leading to side effects such as nausea, fatigue, hair loss, and weakened immunity. Advances in chemotherapy protocols are now focused on reducing these side effects through precision medicine and targeted delivery, ensuring better outcomes for children.
Surgery
Surgery is often used to remove solid tumours or cancerous tissue and plays a vital role in treating certain types of childhood cancers. Surgeons work to extract as much of the tumour as possible while preserving nearby healthy tissue. For cancers like neuroblastoma or Wilms tumour, surgery may be the primary treatment or part of a multimodal approach alongside chemotherapy and radiation. Advances in surgical techniques, including minimally invasive and robotic-assisted procedures, have improved precision and recovery times. Despite its efficacy, surgery carries risks such as infection and complications related to anaesthesia, which are carefully managed in paediatric care settings.
Stem Cell (Bone Marrow) Transplantation
Stem cell transplantation is a lifesaving treatment for children with cancers such as leukaemia or lymphoma that do not respond to other therapies. This procedure involves replacing damaged or destroyed bone marrow with healthy stem cells, either from the child or a donor. The healthy cells rebuild the bone marrow, enabling the production of normal blood cells. While highly effective, the procedure requires intensive preparation, including high-dose chemotherapy or radiation, and poses risks such as infection or graft-versus-host disease. Despite these challenges, stem cell transplants have revolutionised outcomes for many children with complex cancers.
Immunotherapy
Immunotherapy harnesses the power of the child’s immune system to recognise and attack cancer cells. This innovative treatment includes approaches like monoclonal antibodies, immune checkpoint inhibitors, and CAR-T cell therapy, which are particularly effective for cancers such as certain leukaemia and lymphomas. Immunotherapy is often used when traditional treatments fail or as part of a combined regimen. Side effects, such as inflammation and flu-like symptoms, are typically less severe than those from chemotherapy or radiation. As a cutting-edge treatment, immunotherapy continues to evolve, offering new hope for children with difficult-to-treat cancers. Proton theraphy offeres a promising future for pediatric cancer.
Side effects, such as fatigue, developmental delays, and long-term complications, are managed through supportive care, including palliative treatments and psychosocial support.
Conclusion
While pediatric cancer poses significant challenges, advancements in medical science offer hope for survival and improved quality of life. The majority of children with cancer achieve remission, with many curable cases. However, lifelong monitoring is essential to address potential late effects, such as organ damage or secondary cancers. By fostering early diagnosis, effective treatment, and ongoing care, healthcare providers and caregivers can ensure a brighter future for pediatric cancer survivors.
To consult the best doctor for The treatment of pediatric cancer, click here
The best hospital for the treatment of pediatric cancer in India, click here
The best hospital for the treatment of pediatric cancer in Bangalore, click here
The best hospital for the treatment of pediatric cancer in Chennai, click here
The best hospital for the treatment of pediatric cancer in Delhi, click here
The best hospital for the treatment of pediatric cancer in Hyderabad, click here
The best hospital for the treatment of pediatric cancer in Mumbai, click here

